• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术治疗 TURBT 不适用的 pT1 尿路上皮癌:长期结果。

Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.

机构信息

Department of Urologic Surgery, Tianjin Medical University Second Hospital, Tianjin, China.

Department of Radiology, Tianjin Medical University Second Hospital, Tianjin, China.

出版信息

Eur J Surg Oncol. 2019 Oct;45(10):1993-1999. doi: 10.1016/j.ejso.2019.07.018. Epub 2019 Jul 16.

DOI:10.1016/j.ejso.2019.07.018
PMID:31327502
Abstract

PURPOSE

This study sought to identify factors associated with survival of pT1 urothelial carcinoma of bladder (UCB) after radical cystectomy (RC).

METHODS

This study consists of 114 pT1 UCB [primary 83, recurrent 31, none were amenable to transurethral resection (TUR)] treated by radical cystectomy. Survival analysis using Cox regression tests were performed to identify factors associated with survival of pT1 UCB after RC.

RESULTS

Pelvic lymph node (LN) status, age and lymphovascular invasion (LVI) are associated with survival of pT1 UCB after RC; recurrent pT1 UCB of high grade origin (HGO) tends to have poorer CSS than primary pT1 UCB or recurrent pT1 UCB of low grade origin (LGO) (5-year and 10-year CSS rates was 75% and 73% for primary cases; 77% and 77% for recurrent pT1 UCB of LGO; and 56% and 37% for recurrent pT1 UCB of HGO, p = 0.078).

CONCLUSIONS

LN status, age and LVI were significantly associated with survival of pT1 UCB after RC. Recurrent pT1 UCB of HGO should be managed with radical cystectomy in a timely fashion given that these cases tend to have poorer CSS than primary pT1 UCB after RC, even if they did not progress to muscle-invasive bladder cancer (MIBC).

摘要

目的

本研究旨在确定与根治性膀胱切除术(RC)后 pT1 膀胱尿路上皮癌(UCB)生存相关的因素。

方法

本研究包括 114 例 pT1 UCB [原发性 83 例,复发性 31 例,均不可行经尿道切除术(TUR)]接受 RC 治疗。采用 Cox 回归检验进行生存分析,以确定与 RC 后 pT1 UCB 生存相关的因素。

结果

盆腔淋巴结(LN)状态、年龄和脉管侵犯(LVI)与 RC 后 pT1 UCB 的生存相关;高级别起源的复发性 pT1 UCB(HGO)的 CSS 倾向于比原发性 pT1 UCB 或低级别起源的复发性 pT1 UCB(LGO)更差(5 年和 10 年 CSS 率分别为原发性病例的 75%和 73%;LGO 的复发性 pT1 UCB 为 77%和 77%;HGO 的复发性 pT1 UCB 为 56%和 37%,p=0.078)。

结论

LN 状态、年龄和 LVI 与 RC 后 pT1 UCB 的生存显著相关。由于这些病例在 RC 后 CSS 倾向于比原发性 pT1 UCB 更差,即使它们没有进展为肌层浸润性膀胱癌(MIBC),HGO 的复发性 pT1 UCB 也应及时进行 RC 治疗。

相似文献

1
Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.根治性膀胱切除术治疗 TURBT 不适用的 pT1 尿路上皮癌:长期结果。
Eur J Surg Oncol. 2019 Oct;45(10):1993-1999. doi: 10.1016/j.ejso.2019.07.018. Epub 2019 Jul 16.
2
Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.脉管浸润、输尿管再植和膀胱癌病史与盆腔淋巴结阴性的肌层浸润性膀胱癌行部分膀胱切除术的不良预后相关。
Eur J Surg Oncol. 2013 Oct;39(10):1150-6. doi: 10.1016/j.ejso.2013.04.006. Epub 2013 May 27.
3
Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.脉管浸润与根治性膀胱切除术后病理分期为 T1 且淋巴结阴性的患者膀胱癌复发和生存独立相关。
BJU Int. 2013 Jun;111(8):1215-21. doi: 10.1111/j.1464-410X.2012.11455.x. Epub 2012 Nov 26.
4
The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.淋巴血管侵犯对根治性膀胱切除术时升期和淋巴结转移风险的影响。
Eur Urol Focus. 2020 Mar 15;6(2):292-297. doi: 10.1016/j.euf.2018.09.019. Epub 2018 Oct 5.
5
Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.在经尿道膀胱肿瘤切除术再分期时,对于残余 T1 膀胱癌患者,即刻根治性膀胱切除术的作用。
BJU Int. 2013 Jul;112(1):54-9. doi: 10.1111/j.1464-410X.2012.11391.x. Epub 2012 Nov 13.
6
The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.变异组织学分化对接受根治性膀胱切除术的淋巴结阳性膀胱癌患者的结外扩散及生存的影响。
Surg Oncol. 2019 Mar;28:208-213. doi: 10.1016/j.suronc.2019.01.008. Epub 2019 Jan 30.
7
Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.在接受根治性膀胱切除术的膀胱癌患者中,他汀类药物的使用对肿瘤学结局的影响。
J Urol. 2013 Aug;190(2):487-92. doi: 10.1016/j.juro.2013.02.003. Epub 2013 Feb 8.
8
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.在接受根治性膀胱切除术的淋巴结阴性膀胱癌患者中,盆腔淋巴结清扫术时解剖的淋巴结数量与癌症特异性生存的关系。
Ann Surg Oncol. 2011 Jul;18(7):2018-25. doi: 10.1245/s10434-010-1538-6. Epub 2011 Jan 19.
9
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.pT4a期膀胱尿路上皮癌根治性膀胱切除术后癌症特异性生存的预测:一种临床决策工具的开发
BJU Int. 2016 Feb;117(2):272-9. doi: 10.1111/bju.12984. Epub 2015 May 24.
10
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.在病理肿瘤分期 T4a 的膀胱癌患者中,根治性膀胱切除术治疗后的癌症特异性生存的性别特异性差异。
Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6.

引用本文的文献

1
Prognostic factors in T1 high-grade urothelial carcinoma of the bladder with lymphovascular invasion: a retrospective cohort study.伴有淋巴管浸润的膀胱T1期高级别尿路上皮癌的预后因素:一项回顾性队列研究
Int Urol Nephrol. 2025 Feb 1. doi: 10.1007/s11255-025-04391-8.